Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
Johnson & Johnson's 3Q earnings in spotlight next week following Kenvue split
02:08pm, Friday, 13'th Oct 2023
Johnson & Johnson (NYSE:JNJ) is slated to report earnings before the market opens on Tuesday in what will be the company's first report since spinning off its consumer health division, Kenvue. For i
7 High-Growth S&P 500 Stocks to Buy Now
01:52pm, Thursday, 12'th Oct 2023
While publicly traded securities that benefit from significant upside potential usually carry a higher-risk profile, with high-growth S&P 500 stocks, you can almost get the best of both worlds. To be
IPOs are out of fashion. Here's what companies are doing instead.
11:39am, Friday, 06'th Oct 2023
While the current deal landscape on Wall Street remains low on M&A, initial public offerings (IPOs), and other transactions, corporate spinoffs are chugging along.
2 Magnificent Dividend Kings to Buy Now
06:00am, Thursday, 05'th Oct 2023
Coca-Cola and J&J both have long track records of increasing dividend payments to shareholders. These companies also offer bright earnings prospects well into the future, thanks to their solid product
Here's Why Kenvue Stock Is (Slightly) Riskier Than It Seems
08:36am, Wednesday, 04'th Oct 2023
Kenvue is a fairly safe stock, thanks to its consistent sales of critical goods. However, it doesn't have many opportunities to expand more rapidly than it is now.
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
06:00am, Sunday, 01'st Oct 2023
J&J recently spun off its billion-dollar consumer health business to form Kenvue. Kenvue announced a dividend during its first earnings report as an independent entity.
Is Kenvue Stock Too Pricey to Buy?
09:22am, Saturday, 30'th Sep 2023
Kenvue's shares are pricey because it's expected to be a safe bet for investors. Its growth rate is relatively low for its valuation, at least so far.
3 Best Stocks to Buy in September and Hold Forever
07:41am, Sunday, 24'th Sep 2023
Kenvue is poised to make its mark as a great business with a new name. Abbott Labs has long-term upside in key healthcare end markets.
Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
06:30am, Friday, 22'nd Sep 2023
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its financial results for the third quarter ending October 1, 2023, before market open on October 26, 2023.
Here are the 14 stocks Jim Cramer is watching, including Apple, Goldman Sachs, Amazon
09:41am, Wednesday, 20'th Sep 2023
Here are some of the tickers on my radar for Wednesday, Sept. 20, taken directly from my reporter's notebook.
2 Incredibly Cheap Dividend Stocks to Buy Now
08:30am, Wednesday, 20'th Sep 2023
High-quality dividend stocks tend to trade at enormous premiums. AT&T and Kenvue both trade at attractive multiples.
Kenvue Is Not The Better Johnson & Johnson, Also Not For Dividend Investors
05:53am, Tuesday, 19'th Sep 2023
Kenvue faces significant challenges in the consumer healthcare sector, including sluggish growth, intense competition, and middle-tier brand positions. While the company has manageable debt levels, it
Kenvue: Interesting Times
12:19pm, Monday, 18'th Sep 2023
Kenvue's shares have fallen since its IPO due to high valuations and concerns about its growth composition. The company, a spin-off from Johnson & Johnson, is well-diversified with leading brands in c
Johnson & Johnson: Kenvue Spin-Off Unlikely To Drive Market-Beating Returns
12:58am, Monday, 18'th Sep 2023
Johnson & Johnson had spun off Kenvue, its consumer health division, to boost growth in its more profitable pharmaceutical and medical technology sectors. JNJ achieved a steady 3.3% revenue growth ove
3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income
11:09am, Sunday, 17'th Sep 2023
American Tower has increased its payout every year since becoming a REIT. Brookfield Renewable has boosted its dividend by at least 5% annually over the past 12 years.
